Trending Market News
Pfizer announced on Monday that its experimental drug for a type of lung cancer failed to meet the primary endpoint in a late-stage clinical trial. The setback represents a clinical development failure for the pharmaceutical company in oncology. No additional details about the specific drug, cancer type, or next steps were provided in the brief announcement.
- The drug missed its main goal in a late-stage trial, indicating it did not demonstrate sufficient efficacy for its intended lung cancer indication
- Late-stage trial failures typically represent significant setbacks as they occur after substantial investment in drug development
- The announcement lacked specifics on the drug candidate, the exact type of lung cancer being targeted, or whether Pfizer plans to continue development
Canadian auto union Unifor began contract negotiations with Ford Motor on Monday, representing nearly 19,000 workers at Ford, GM, and Stellantis ahead of the September 20 contract expiration. The union set a July 10 deadline to reach a deal with Ford first, which will serve as a template for negotiations with the other two automakers, amid concerns about U.S. tariffs and economic conditions.
- Unifor chose Ford as the lead negotiator because the company has shown the strongest commitment to maintaining operations in Canada
- Nearly 6,000 workers have been laid off across the three automakers' plants as companies have shifted or paused production at several facilities
- The union started talks earlier than usual due to worsening economic conditions and pending U.S. tariffs related to negotiations around the U.S.-Canada-Mexico trade agreement
Alphabet's stock fell 7% Monday morning, marking its worst day in a year, following the departure of two high-profile AI researchers to rivals OpenAI and Anthropic. The selloff reflects investor concerns about AI commoditization and the company's massive capital expenditures, with Microsoft's CEO publicly questioning whether heavy AI spending by giants is building durable advantages.
- Google lost VP of engineering Noam Shazeer (co-lead of Gemini AI models) to OpenAI and Nobel Prize winner John Jumper (AlphaFold creator) to Anthropic within days of each other
- Alphabet has raised $141 billion in debt and equity since October to fund AI investments, but faces questions about returns if AI models become commoditized
- Microsoft CEO Satya Nadella stated the AI market has become commoditized and called for less dependence on 'AI Giants', adding pressure to Alphabet's AI spending justification
Disney-owned ABC launched an on-air campaign on Monday asking viewers to support the network in two separate disputes with U.S. government agencies. The Federal Communications Commission ordered early license reviews for ABC's eight owned stations in April following pressure from President Trump, and is also investigating ABC's daytime talk show 'The View' over federal equal time rules for political candidates.
- The FCC ordered ABC to file early license reviews for its eight company-owned television stations after President Trump pressured the regulatory agency to take action
- The FCC is separately investigating ABC's 'The View' talk show after declaring it subject to federal equal time rules for political candidates
- ABC is mobilizing viewer support through an on-air campaign to back the network in both ongoing battles with the government
Brazil's state-owned oil company Petrobras and Mexico's Pemex are signing memorandums of understanding on Tuesday for technical and strategic cooperation on oil and gas projects. The agreements will be signed at an event in Rio de Janeiro attended by both companies' CEOs. This partnership aims to enhance collaboration between Latin America's two major state-run energy firms.
- The signing ceremony will take place in Rio de Janeiro with both CEOs present, marking a formal collaboration between the two state-owned oil giants
- The memorandums cover technical and strategic cooperation specifically focused on oil and gas projects between the companies
- This partnership represents increased regional energy cooperation between Brazil and Mexico's national oil companies
Uber Technologies' board of directors, including CEO Dara Khosrowshahi, was sued on Monday in San Francisco federal court over compliance failures related to sexual harassment lawsuits. The lawsuit targets the board's oversight responsibilities in connection with the company's handling of sexual harassment issues.
- The lawsuit was filed in San Francisco federal court against Uber's board of directors
- CEO Dara Khosrowshahi is named among the defendants in the case
- The suit alleges compliance failures specifically linked to sexual harassment lawsuits against the company
Indian fintech company CRED announced it will raise approximately $900 million from Meta Platforms at a post-money valuation of $4.5 billion. The investment aims to accelerate CRED's growth and prepare the company for an eventual initial public offering in the stock market.
- Meta Platforms is investing $900 million in the Indian fintech firm
- The deal values CRED at $4.5 billion post-money valuation
- Funds will be used to accelerate growth and prepare for a future stock market listing
Lloyds Banking Group is considering acquiring Aldermore, a British lender being sold by South Africa's FirstRand amid a motor finance mis-selling scandal. FirstRand announced its exit in April after raising provisions for mis-sold motor loans to £750 million ($994 million). Any potential buyer will likely require protection against further compensation liabilities related to the ongoing UK regulatory investigation.
- Lloyds is examining Aldermore for its small business lending and project finance capabilities, though no formal bid is certain
- FirstRand raised provisions for mis-sold motor loans to £750 million and cited the 'deeply flawed' situation as reason for exiting its British challenger bank
- Rival lender Shawbrook is also exploring a combination with Aldermore, and any buyer will likely seek indemnity against further compensation liabilities
Electric vehicle maker Lucid Group announced on Monday it will cut approximately 18% of its U.S. workforce. The layoffs represent a significant reduction in staffing for the EV manufacturer as the industry faces ongoing challenges. The cuts will impact employees at Lucid's U.S. operations.
- Lucid Group is reducing its U.S. workforce by about 18% in a major restructuring move
- The announcement comes as EV makers face increased pressure from slowing demand and intensifying competition in the electric vehicle market
- Lucid operates manufacturing facilities in the U.S., including a plant in Casa Grande, Arizona
UPS is investing $48 million to upgrade 27 temperature-controlled facilities across the Americas, Europe, and Asia to capitalize on the booming healthcare logistics market. The investment aims to improve cold-chain capabilities for pharmaceuticals like GLP-1 drugs that require strict temperature control during transit. UPS has identified healthcare as one of its biggest growth opportunities amid rising demand for temperature-sensitive biologics.
- The temperature-sensitive biologics market is projected to grow at an 8.3% compound annual growth rate through 2033, reaching approximately $39.1 billion in market value
- Up to 50% of global vaccines are wasted annually, with a significant portion due to cold-chain storage failures, highlighting the critical need for improved logistics infrastructure
- The investment responds to the meteoric rise of GLP-1 drugs like Wegovy and Ozempic, which one in eight Americans are taking and which require strict refrigeration during shipping
Britain is expected to break its June temperature record this week, with forecasts predicting up to 39°C (102.2°F), surpassing the 1957 record of 35.6°C. Authorities issued only their second-ever extreme heat-health alert, warning of risks even to healthy individuals as the heatwave spreads from western Europe across southern and central England and parts of Wales.
- Temperatures could exceed 39°C mid-week, with high humidity creating heat stress dangers and 'tropical nights' where temperatures stay above 20°C through the night
- The heat-health alert follows deadly impacts in France, where three elderly people died and schools closed as temperatures were forecast to exceed 42°C
- Hospitals, schools, and transport services are bracing for disruption, with conditions expected to cool to around 32°C by Friday
Merck announced that its experimental drug successfully met the primary endpoint in a late-stage clinical trial for patients with a type of inflammatory bowel disease. This positive result represents a significant milestone in the drug's development and could lead to a new treatment option for IBD patients. The announcement was made on June 22.
- The drug achieved its main goal in a late-stage trial, indicating efficacy in treating inflammatory bowel disease
- Late-stage trial success typically represents the final testing phase before seeking regulatory approval for commercialization
- The positive data could expand Merck's gastroenterology portfolio and address unmet medical needs in the IBD market
Alan Greenspan, who served as Federal Reserve Chairman for 19 years under four presidents from 1987 to 2006, has died at age 100 from complications of Parkinson's Disease. His tenure, the second-longest in Fed history, spanned major economic events including the 1987 Black Monday crash, the dot-com bubble, and multiple financial crises. Greenspan became known for his deliberate use of obfuscating language, dubbed 'Fedspeak,' to avoid prematurely revealing monetary policy intentions.
- His famous 'irrational exuberance' comment in December 1996 initially caused global markets to tumble, though they recovered and continued climbing until the dot-com bust in 2001.
- Greenspan later acknowledged he failed to recognize the significance of risky subprime lending practices until late 2005-2006, which contributed to the housing bubble and subsequent Great Recession.
- In January 2026, he joined other former Fed and Treasury officials in signing a statement criticizing reported criminal inquiries into current Fed Chair Jay Powell as an 'unprecedented attempt' to undermine central bank independence.
The FDA will reverse its February rejection of Regenxbio's gene therapy Navsunli for Hunter syndrome, according to the Wall Street Journal. The company plans to resubmit its application in the third quarter following a July meeting with regulators. The initial rejection cited uncertainty over the trial design.
- Regenxbio will refile its application for Navsunli in Q3 after a formal FDA meeting expected in July
- The FDA originally rejected the rare-disease gene therapy in February due to concerns about trial design uncertainty
- The reversal allows Regenxbio another opportunity to gain approval for treating Hunter syndrome, a rare genetic disorder
Shipping through the Strait of Hormuz, which handles approximately 20% of global oil traffic, stalled over the weekend after Iran declared the waterway closed again, citing Israeli ceasefire violations in Lebanon. Despite Iran's claims, maritime data shows some vessels, primarily Iranian-flagged tankers, continued transiting the strait, though overall traffic dropped sharply from over 21 ships on Saturday to 12 on Sunday. The closure threatens a fragile recovery in shipping that began after the U.S. and Iran signed a memorandum of understanding last week.
- Traffic through the strait dropped to 12 ships on Sunday from 21 the previous day, with 5 of 8 inbound vessels 'going dark' by disabling their tracking systems - far below prewar levels of over 100 ships daily
- U.S. and Iranian delegations held talks in Switzerland on Sunday to finalize a 60-day deal that would reopen the strait toll-free and end hostilities in Lebanon, with officials describing the negotiations as 'constructive but tense'
- The U.S. military denied Iran's claims of closure, stating 'Iran does not control the Strait of Hormuz,' while at least 15 Iran-flagged oil tankers were observed leaving the Gulf of Oman with active tracking signals
China imposed trade restrictions on dozens of U.S. companies in retaliation for the Pentagon adding Chinese technology firms to its military-linked entities blacklist earlier this month. China's Commerce Ministry placed 10 American industrial suppliers on its export control list, while the Finance Ministry excluded 46 U.S. companies from government procurement projects. Analysts view the measures as largely symbolic rather than a substantive escalation in U.S.-China relations.
- The 10 U.S. companies on China's export control list include rare earth miners MP Materials and USA Rare Earth, drone makers Teal Drones and Jaia Robotics, and military equipment provider Oshkosh Defense, barring them from receiving dual-use items from China.
- The Pentagon's earlier action added Chinese tech companies including Tencent, CATL, and carmaker BYD to its 1260H list, which prohibits direct Defense Department contracts starting June 30 and indirect procurement in 2027.
- Most targeted U.S. companies have little or no meaningful business exposure in China, and analysts believe the countermeasures reflect China's strategy to respond to mild U.S. escalation while maintaining overall relationship stability following last month's Trump-Xi summit.
British technology firm Ocado Group is preparing to appoint a successor to CEO Tim Steiner, according to Sky News. Niklas Heuveldop, currently CEO of Vonage (a subsidiary of Sweden's Ericsson), has reportedly been approached for the role, though Reuters could not immediately verify the report.
- Niklas Heuveldop, CEO of Ericsson subsidiary Vonage, has been sounded out as potential successor to Tim Steiner
- The leadership transition at Ocado Group represents a significant change for the British technology and retail firm
- Reuters has not independently verified Sky News' report on the CEO succession planning
Disney and Pixar's 'Toy Story 5' achieved a franchise-record $160 million domestic opening weekend, with $312 million globally, surpassing 'Toy Story 4's' previous record of $120.9 million in 2019. The film became the second-highest opening for an animated feature ever, trailing only 'Incredibles 2' ($182.7 million in 2018), and is projected to reach $1 billion worldwide.
- The film attracted 11.5 million moviegoers during Father's Day weekend, with over 25% choosing premium large-format screenings
- The Toy Story franchise has generated over $3 billion globally since 1995, with two installments each surpassing $1 billion worldwide
- Animated PG-rated films have dominated the box office over PG-13 and R-rated films in the last two years, with animated features typically showing strong long-term playability
UniCredit reported that investors tendered 12.51% of Commerzbank shares in its takeover bid as of June 19, bringing its total holding to 42.5% of the German bank. The tender uptake represents a modest increase from 12.41% reported earlier in the week. UniCredit launched the bid on May 5, stating it seeks to push its stake above 30% but does not aim for full control.
- UniCredit's overall Commerzbank holding now stands at 42.5%, comprising a 26.77% direct equity stake, 3.22% in derivatives, and 12.51% from the tender offer
- The tender offer acceptance rate increased marginally from 12.41% on Tuesday to 12.51% on Friday, showing limited additional shareholder participation
- UniCredit has stated it does not seek control of Commerzbank but aims to increase its stake above the 30% threshold, which typically triggers takeover regulations
The U.S. has launched a Section 301 trade investigation into Germany's pharmaceutical pricing policies, alleging 'persistent underpayment' for medicines is discriminatory. The probe targets Germany's cost-saving healthcare reforms, which include higher discounts from pharmaceutical companies, amid concerns that American patients are subsidizing lower drug prices abroad.
- Germany proposed overhauling its health insurance system in April to reduce public health spending, including higher discounts for insurance funds from the pharma industry
- The investigation uses Section 301 of the Trade Act, which allows unilateral U.S. action against countries with unfair trade practices that burden American commerce
- Multiple pharmaceutical companies have warned they might withdraw or delay new medicines in Germany in response to the proposed cost-saving legislation